The latest autism research news stories with ASF Chief Science Officer Alycia Halladay
Podcast: Play in new window | Download
Subscribe: RSS
This week is a pharmacopeia of inflation. The #ASFpodcast talks debilitating gastrointestinal issues and new efforts to understand and treat them (including the CANDID meeting www.candidgi.com), a new method to understand adverse events in those that cannot report them on their own, and new news on Celexa, which is used to treat anxiety.
info@candidgi.com
https://www.theautismstudy.com
https://pubmed.ncbi.nlm.nih.gov/35165451/
Podcast: Play in new window | Download
Subscribe: RSS
On this week’s podcast, we answer your question: “what’s the evidence of a gut-brain connection”? We can’t answer that question without starting off with a description of the microbiome. The microbiome is the colony of organisms in your gastrointestinal system that is showing increasing evidence of influencing brain function. We asked three experts: Calliope Holingue from JHSPH, Helen Vuong from UCLA and Stewart Campbell of Axial Therapeutics what is happening in research around the microbiome in autism, and what therapeutics are being developed to help those with GI issues and ASD.